Immunological Reviews

Cover image for Vol. 222 Issue 1

Special Issue: Tumor Immunology

April 2008

Volume 222, Issue 1

Pages 5–368

  1. Introduction

    1. Top of page
    2. Introduction
    3. Review articles
    1. You have free access to this content
      Tumor immunology top 10 list (pages 5–8)

      Olivera J. Finn

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00623.x

  2. Review articles

    1. Top of page
    2. Introduction
    3. Review articles
    1. Engineering therapeutic monoclonal antibodies (pages 9–27)

      Xiao-yun Liu, Laurentiu M. Pop and Ellen S. Vitetta

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00601.x

    2. Strategies and challenges in eliciting immunity to melanoma (pages 28–42)

      Andrew R. Ferguson, Lisa A. Nichols, Angela L. Zarling, Elizabeth D. Thompson, C. Colin Brinkman, Kristian M. Hargadon, Timothy N. Bullock and Victor H. Engelhard

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00620.x

    3. Antigen-specific immunotherapy of cervical and ovarian cancer (pages 43–69)

      Chien-Fu Hung, T. C. Wu, Archana Monie and Richard Roden

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00622.x

    4. Immunotherapy of malignant brain tumors (pages 70–100)

      Duane A. Mitchell, Peter E. Fecci and John H. Sampson

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00603.x

    5. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis (pages 117–128)

      Rong Xiang, Yunping Luo, Andreas G. Niethammer and Ralph A. Reisfeld

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00613.x

    6. Multiple roles for CD4+ T cells in anti-tumor immune responses (pages 129–144)

      Richard Kennedy and Esteban Celis

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00616.x

    7. Polarized immune responses differentially regulate cancer development (pages 145–154)

      Magnus Johansson, David G. DeNardo and Lisa M. Coussens

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00600.x

    8. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance (pages 155–161)

      Paola Allavena, Antonio Sica, Cecilia Garlanda and Alberto Mantovani

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00607.x

    9. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells (pages 162–179)

      Ilaria Marigo, Luigi Dolcetti, Paolo Serafini, Paola Zanovello and Vincenzo Bronte

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00602.x

    10. Signaling defects in anti-tumor T cells (pages 192–205)

      Alan B. Frey and Ngozi Monu

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00606.x

    11. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape (pages 206–221)

      Jessica B. Katz, Alexander J. Muller and George C. Prendergast

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00610.x

    12. Cancer vaccines for established cancer: how to make them better? (pages 242–255)

      Daniel M. Andrews, Eugene Maraskovsky and Mark J. Smyth

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00612.x

    13. Reengineering dendritic cell-based anti-cancer vaccines (pages 256–276)

      Gary K. Koski, Peter A. Cohen, Robert E. Roses, Shuwen Xu and Brian J. Czerniecki

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00617.x

    14. Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed (pages 299–315)

      Timo L. M. Ten Hagen, Ann L. B. Seynhaeve and Alexander M. M. Eggermont

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00619.x

    15. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting (pages 316–327)

      Andrew Gray, Adam B. Raff, Maurizio Chiriva-Internati, Si-Yi Chen and W. Martin Kast

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00605.x

    16. The flip side of immune surveillance: immune dependency (pages 341–356)

      Richmond T. Prehn and Liisa M. Prehn

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00609.x

    17. Twelve immunotherapy drugs that could cure cancers (pages 357–368)

      Martin A. ‘Mac’ Cheever

      Article first published online: 19 MAR 2008 | DOI: 10.1111/j.1600-065X.2008.00604.x

SEARCH

SEARCH BY CITATION